This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Novartis Ag, Novartis Pharma Ag. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Susanne Joerg: Innovator in Pharmaceutical Products
Introduction
Susanne Joerg is a notable inventor based in Binningen, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid compositions of IL-17 antibodies. With a total of 8 patents, her work has the potential to impact the treatment of various autoimmune disorders.
Latest Patents
Her latest patents focus on pharmaceutical products and stable liquid compositions of IL-17 antibodies and antigen-binding fragments, such as AIN457 (secukinumab). These disclosures detail processes for creating these pharmaceutical products and compositions. Furthermore, they outline the use of these products and compositions in treating IL-17-mediated disorders, including psoriasis, ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis.
Career Highlights
Susanne Joerg is currently employed at Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to further her research and development in the pharmaceutical sector, contributing to innovative solutions for complex health issues.
Collaborations
One of her notable coworkers is Kathrin Serno-Schersch, who also plays a significant role in their collaborative efforts within the company.
Conclusion
Susanne Joerg's contributions to pharmaceutical innovations, particularly in the area of IL-17 antibodies, highlight her importance in the field. Her work continues to pave the way for advancements in treating autoimmune disorders.